Takeda Pharmaceutical have became the first private sector company to announce a financial commitment to the Global Fund...
Thermo Fisher Scientific has announced that its Oncomine Dx Target Test CDx System has received reimbursement coverage f...
The CureApp nicotine-dependent treatment app is clinically proved as a higher rate of sustained smoking cessation (CAR) ...
Scientists successfully bioengineered human liver organoids that faithfully mimic key features of fatal liver disease in...
Beam Therapeutics and Bio Palette have announced an exclusive cross-license agreement around each companies’ base ...
PENTAX Medical, a leading provider of endo-imaging solutions, will soon celebrate the 100th anniversary of the foundatio...
Japanese multinational conglomerate company Hitachi has signed a contract with Himed Hospital Management (Xuzhou) C...
Japanese firm Chugai Pharmaceutical Co., Ltd. has announced the decision to construct a core research laboratory, C...
Researchers at Okayama University report in the journal Sensors and Actuators B: Chemical that terahertz radia...
Japan headquartered Menicon Co. has announced the launch of the Menicon Bloom Myopia Control Management System...
Japan based B dot Medical Inc. has announced that the company has initiated the development of an ultra-compact pro...
Chugai Pharmaceutical has announced that it has obtained regulatory approval for the humanized anti-human IL-6 receptor ...
Elekta (EKTA-B.ST) has announced that its Elekta Unity magnetic resonance radiation therapy system has been approved for...
Eisai Inc., the U.S. pharmaceutical subsidiary of Japan headquartered Eisai Co., Ltd., has announced the immediate appoi...
Takeda Pharmaceutical and Frazier Healthcare Partners have announced a collaboration to launch Phathom Pharmaceuticals, ...
Takeda Pharmaceutical Company Limited has announced further results from the Phase 3b head-to-head VARSITY study, w...
Japanese pharma company Daiichi Sankyo has announced that the Company has been unable to fulfill its obligation to build...
Eisai Co., Ltd. announced that presentations on a series of abstracts highlighting updates regarding its in-house discov...
Teijin Limited has announced that it has signed a research and development agreement with the Japan Agency for Medical R...
Takeda Pharmaceutical Company has announced that the U.S. Food & Drug Administration (FDA) has accepted for rev...
Daiichi Sankyo has announced the launch in Japan of MINNEBRO® Tablets 1.25 mg, 2.5 mg and 5 mg (generic name: e...
Eisai Co., Ltd. has entered into a license agreement with medac Gesellschaft für klinische Spezialpräparate mb...
Japan headquartered Takeda Pharma has entered into an agreement to sell TachoSil®, a surgical patch designed to achi...
Novartis announced that it has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the asset...
Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, has announced the dosing of a ...
